Low-dose endotoxemia and human neuropsychological functions

Brain, Behavior, and Immunity

Volumn 19, Issue 5, 2005, Pages 453-460

  Krabbe, Karen Suárez ^a   Reichenberg, Abraham ^b   Yirmiya, Raz ^c   Smed, Annelise ^d   Pedersen, Bente Klarlund ^a   Bruunsgaard, Helle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d Rigshospitalet   (Denmark)

Author keywords

Cognitive function; Cytokines; Endotoxin; Inflammation

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CELL COUNT; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMOTION; ENDOTOXEMIA; ESCHERICHIA COLI; HEART RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE COUNT; MALE; MEMORY; NEUROPSYCHOLOGY; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AFFECT; AGING; BLOOD CELL COUNT; COGNITION; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; EMOTIONS; ENDOTOXEMIA; ENDOTOXINS; HUMANS; INTERLEUKIN-6; LEARNING; LEUKOCYTE COUNT; MALE; MEMORY; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23044485072     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2005.04.010     Document Type: Article

References (43)

1. S.M. Allan, and N.J. Rothwell Cytokines and acute neurodegeneration Nat. Rev. Neurosci. 2 2001 734 744
2. X.A. Alvarez, A. Franco, L. Fernandez-Novoa, and R. Cacabelos Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease Mol. Chem. Neuropathol. 29 1996 237 252
3. A. Avital, I. Goshen, A. Kamsler, M. Segal, K. Iverfeldt, G. Richter-Levin, and R. Yirmiya Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity Hippocampus 13 2003 826 834
4. J.I. Barzilay, L. Abraham, S.R. Heckbert, M. Cushman, L.H. Kuller, H.E. Resnick, and R.P. Tracy The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study Diabetes 50 2001 2384 2389
5. H. Bruunsgaard, K. Andersen-Ranberg, B. Jeune, A.N. Pedersen, P. Skinhoj, and B.K. Pedersen A high plasma concentration of TNF-alpha is associated with dementia in centenarians J. Gerontol. A Biol. Sci. Med. Sci. 54 1999 M357 M364
6. O. Cohen, A. Reichenberg, C. Perry, D. Ginzberg, T. Pollmacher, H. Soreq, and R. Yirmiya Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase J. Mol. Neurosci. 21 2003 199 212
7. R. Dantzer, R.M. Bluthe, S. Laye, J.L. Bret-Dibat, P. Parnet, and K.W. Kelley Cytokines and sickness behavior Ann. NY Acad. Sci. 840 1998 586 590
8. B.B. Duncan, M.I. Schmidt, J.S. Pankow, C.M. Ballantyne, D. Couper, A. Vigo, R. Hoogeveen, A.R. Folsom, and G. Heiss Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 52 2003 1799 1805
9. R.J. Elin, S.M. Wolff, K.P. McAdam, L. Chedid, F. Audibert, C. Bernard, and F. Oberling Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans J. Infect. Dis. 144 1981 329 336
10. M.J. Engelhart, M.I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg, J.C. van Swieten, T. Stijnen, A. Hofman, J.C. Witteman, and M.M. Breteler Inflammatory proteins in plasma and the risk of dementia: the rotterdam study Arch. Neurol. 61 2004 668 672
11. A. Festa, R. D'Agostino Jr., R.P. Tracy, and S.M. Haffner Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study Diabetes 51 2002 1131 1137
12. E.S. Ford Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults Am. J. Epidemiol. 155 2002 57 64
13. D.J. Freeman, J. Norrie, M.J. Caslake, A. Gaw, I. Ford, G.D. Lowe, D.S. O'Reilly, C.J. Packard, and N. Sattar C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study Diabetes 51 2002 1596 1600
14. M.J. Garton, G. Keir, M.V. Lakshmi, and E.J. Thompson Age-related changes in cerebrospinal fluid protein concentrations J. Neurol. Sci 104 1991 74 80
15. T.S. Han, N. Sattar, K. Williams, C. Gonzalez-Villalpando, M.E. Lean, and S.M. Haffner Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico city diabetes study Diab. Care 25 2002 2016 2021
16. K.S. Krabbe, M. Pedersen, and H. Bruunsgaard Inflammatory mediators in the elderly Exp. Gerontol. 39 2004 687 699
17. R. Krogh-Madsen, K. Moller, F. Dela, G. Kronborg, S. Jauffred, and B.K. Pedersen Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans Am. J. Physiol. Endocrinol. Metab. 286 2004 E766 E772
18. F. Licastro, S. Pedrini, L. Caputo, G. Annoni, L.J. Davis, C. Ferri, V. Casadei, and L.M. Grimaldi Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol. 103 2000 97 102
19. R.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, P.A. Tataranni, W.C. Knowler, and J. Krakoff Adiponectin and development of type 2 diabetes in the pima Indian population Lancet 360 2002 57 58
20. K.M. Mattila, T. Pirttila, K. Blennow, A. Wallin, M. Viitanen, and H. Frey Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol. Scand. 89 1994 192 198
21. C.A. Meyers Mood and cognitive disorders in cancer patients receiving cytokine therapy Adv. Exp. Med. Biol. 461:75-81. 1999 75 81
22. K. Moller, G.I. Strauss, J. Qvist, L. Fonsmark, G.M. Knudsen, F.S. Larsen, K.S. Krabbe, P. Skinhoj, and B.K. Pedersen Cerebral blood flow and oxidative metabolism during human endotoxemia J. Cereb. Blood Flow Metab. 22 2002 1262 1270
23. J. Mullington, C. Korth, D.M. Hermann, A. Orth, C. Galanos, F. Holsboer, and T. Pollmacher Dose-dependent effects of endotoxin on human sleep Am. J. Physiol. Regul. Integr. Comp. Physiol. 278 2000 R947 R955
24. N. Nakanishi, H. Yoshida, Y. Matsuo, K. Suzuki, and K. Tatara White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men Diabetologia 45 2002 42 48
25. L. Nybo, K. Moller, B.K. Pedersen, B. Nielsen, and N.H. Secher Association between fatigue and failure to preserve cerebral energy turnover during prolonged exercise Acta Physiol. Scand. 179 2003 67 74
26. L. Nybo, B. Nielsen, B.K. Pedersen, K. Moller, and N.H. Secher Interleukin-6 release from the human brain during prolonged exercise J. Physiol. 542 2002 991 995
27. W. Pan, and A.J. Kastin Polypeptide delivery across the blood-brain barrier Curr. Drug Targets. CNS. Neurol. Disord. 3 2004 131 136
28. A.M.W. Petersen, and B.K. Pedersen The anti-inflammatory effect of exercise J. Appl. Physiol. 98 2005 1154 1162
29. T. Pollmacher, M. Haack, A. Schuld, A. Reichenberg, and R. Yirmiya Low levels of circulating inflammatory cytokines-do they affect human brain functions Brain Behav. Immun. 16 2002 525 532
30. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
31. C.R. Pugh, K. Kumagawa, M. Fleshner, L.R. Watkins, S.F. Maier, and J.W. Rudy Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning Brain Behav. Immun. 12 1998 212 229
32. A. Reichenberg, R. Yirmiya, A. Schuld, T. Kraus, M. Haack, A. Morag, and T. Pollmacher Cytokine-associated emotional and cognitive disturbances in humans Arch. Gen. Psychiatry 58 2001 445 452
33. R. Ross Atherosclerosis-an inflammatory disease New Engl. J. med. 340 1999 115 126
34. K.N. Shaw, S. Commins, and S.M. O'Mara Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus Behav. Brain. Res. 124 2001 47 54
35. O. Spreen, and E. Strauss A compendium of neuropsychological tests: administration, norms, and commentary 1988 Oxford University Press Oxford
36. R. Starkie, S.R. Ostrowski, S. Jauffred, M. Febbraio, and B.K. Pedersen Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans FASEB J. 17 2003 884 886
37. The Psychological Corporation, 1997. WAIS-III WMS-III Technical Manual 1997.
38. K.J. Tracey The inflammatory reflex Nature 420 2002 853 859
39. B. Vozarova, C. Weyer, R.S. Lindsay, R.E. Pratley, C. Bogardus, and P.A. Tataranni High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes Diabetes 51 2002 455 461
40. C.J. Wilson, C.E. Finch, and H.J. Cohen Cytokines and cognition-the case for a head-to-toe inflammatory paradigm J. Am. Geriatr. Soc. 50 2002 2041 2056
41. K. Yaffe, K. Lindquist, B.W. Penninx, E.M. Simonsick, M. Pahor, S. Kritchevsky, L. Launer, L. Kuller, S. Rubin, and T. Harris Inflammatory markers and cognition in well-functioning African-American and white elders Neurology 61 2003 76 80
42. K. Yaffe, A. Kanaya, K. Lindquist, E.M. Simonsick, T. Harris, R.I. Shorr, F.A. Tylavsky, and A.B. Newman The metabolic syndrome, inflammation, and risk of cognitive decline JAMA 292 2004 2237 2242
43. R. Yirmiya, G. Winocur, and I. Goshen Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning Neurobiol. Learn. Mem. 78 2002 379 389